Cargando…

Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia

BACKGROUND: Antipsychotic treatment-induced hyperprolactinemia is a highly distressing and disabling side effect for patients. The use of add-on aripiprazole has been identified as a possible treatment strategy in this situation. However, data on prolactin changes with add-on aripiprazole in a real-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raveendranthan, Dhanya, Rao, Naren P., Rao, Mukund G., Mangot, Ajish G., Varambally, Shivaram, Kesavan, Muralidharan, Venkatasubramanian, Ganesan, Gangadhar, Bangalore N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795677/ https://www.ncbi.nlm.nih.gov/pubmed/29403128 http://dx.doi.org/10.4103/IJPSYM.IJPSYM_147_17

Ejemplares similares

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Chlorpromazine Induced Cataract in a Young Patient with Schizophrenia
por: Divakaran, Anjith, et al.
Publicado: (2010)

Acyclovir in Bipolar Disorder: A Mismatched Combination?
por: Jayaram, Naveen, et al.
Publicado: (2011)

Obsessive Compulsive Disorder Masquerading as Psychosis
por: Raveendranathan, Dhanya, et al.
Publicado: (2012)

Successful Use of Add - On Topiramate for Antipsychotic - Induced Weight Gain
por: Shivakumar, Venkataram, et al.
Publicado: (2012)

Successful use of modafinil in treatment-resistant bipolar depression in an elderly woman
por: Agarwal, Sri Mahavir, et al.
Publicado: (2012)

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
por: Kotorki, Paraskevi, et al.
Publicado: (2010)

Aripiprazole-induced priapism
por: Trivedi, Satya K., et al.
Publicado: (2016)

A Longitudinal Study of Relation between Side-effects and Clinical Improvement in Schizophrenia: Is There a Neuro-metabolic Threshold for Second Generation Antipsychotics?
por: Venkatasubramanian, Ganesan, et al.
Publicado: (2013)

Proton magnetic resonance spectroscopy in depression
por: Rao, Naren P., et al.
Publicado: (2011)

Entorhinal Cortex Volume in Antipsychotic-naïve Schizophrenia
por: Jose, Sam P., et al.
Publicado: (2012)

Neurological soft signs in schizophrenia – The past, the present and the future
por: Varambally, Shivarama, et al.
Publicado: (2012)

Yoga school of thought and psychiatry: Therapeutic potential
por: Rao, Naren P., et al.
Publicado: (2013)

Thalamic Shape Abnormalities in Antipsychotic Naïve Schizophrenia
por: Danivas, Vijay, et al.
Publicado: (2013)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022)

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
por: Li, Xianbin, et al.
Publicado: (2013)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar, Fatemeh, et al.
Publicado: (2015)

DIFFERENTIAL THERAPEUTIC EFFECTS OF ADD-ON GROUP V/S INDIVIDUAL YOGA THERAPY IN UNIPOLAR DEPRESSION: A SINGLE BLINDED RANDOMIZED CONTROLLED STUDY
por: Dua, Pratham, et al.
Publicado: (2022)

Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials
por: MENG, Meiling, et al.
Publicado: (2015)

Inferior Parietal Lobule Volume and Schneiderian First-Rank Symptoms in Antipsychotic-Naïve Schizophrenia: A 3-Tesla MRI Study
por: Danivas, Vijay, et al.
Publicado: (2009)

Pars Triangularis Volume Asymmetry and Schneiderian First Rank Symptoms in Antipsychotic-naïve Schizophrenia
por: Shivakumar, Venkataram, et al.
Publicado: (2021)

Neurohemodynamic correlates of ‘OM’ chanting: A pilot functional magnetic resonance imaging study
por: Kalyani, Bangalore G, et al.
Publicado: (2011)

Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016)

Relationship between Brain-Derived Neurotrophic Factor and Schneiderian First Rank Symptoms in Antipsychotic-Naïve Schizophrenia
por: Kalmady, Sunil Vasu, et al.
Publicado: (2013)

Aripiprazole-induced Hyperprolactinemia in a Young Female with Delusional Disorder
por: Joseph, Sam Padamadan
Publicado: (2016)

Rimonabant-induced depression in schizophrenia
por: Arasappa, Rashmi, et al.
Publicado: (2014)

Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
por: Rosenbloom, Arlan L.
Publicado: (2010)

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)

Volume and Asymmetry Abnormalities of Insula in Antipsychotic-Naive Schizophrenia: A 3-Tesla Magnetic Resonance Imaging Study
por: Virupaksha, Harve Shanmugam, et al.
Publicado: (2012)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

Do antipsychotics limit disability in schizophrenia? A naturalistic comparative study in the community
por: Thirthalli, Jagadisha, et al.
Publicado: (2010)

Correction: Hyperprolactinemia with antipsychotic drugs in children and adolescents
por: Rosenbloom, Arlan L
Publicado: (2013)

Hyperprolactinemia with antipsychotics and the need for magnetic resonance imaging
por: Molina Liétor, M.D.C., et al.
Publicado: (2022)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
por: Montejo, A.L., et al.
Publicado: (2022)

Kleptomania: Beyond serotonin
por: Mangot, Ajish G.
Publicado: (2014)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae–Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Ling, et al.
Publicado: (2021)

Relationship between Interleukin-6 Gene Polymorphism and Hippocampal Volume in Antipsychotic-Naïve Schizophrenia: Evidence for Differential Susceptibility?
por: Kalmady, Sunil Vasu, et al.
Publicado: (2014)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2cbcvtrg8c41hg17f3n40fdu1j